RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy
2016 ◽
Vol 82
◽
pp. 256-268
◽
2013 ◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 44
(4)
◽
pp. 558-569
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 59
(1)
◽
pp. 121-130
◽
Keyword(s):
Keyword(s):
1994 ◽
Vol 7
(1)
◽
pp. 23-28
◽
Keyword(s):
Keyword(s):